Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is -8.59% vs 10.20% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -28.05% vs -7.42% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is -18.48% vs -8.29% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is -3.70% vs -6.90% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Anhui Fengyuan Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 15.49% vs -8.12% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -8.59% vs 10.20% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 1.07% vs 196.03% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -28.05% vs -7.42% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -5.86% vs 105.54% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -18.48% vs -8.29% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -6.02% vs 13.70% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -3.70% vs -6.90% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






